Company Active LTD

Company profile

Braintrain2020 Limited

Braintrain2020 Limited is a UK company with status active founded in 2013.

CRN
08660886
Founded
2013
Age
12

Overview

Legal name
BRAINTRAIN2020 LIMITED
Region
Unknown
Registered address
KROTO INNOVATION CENTRE NORTH CAMPUS UNIVERSITY OF SHEFFIELD
318 BROAD LANE
SHEFFIELD
SOUTH YORKSHIRE
UNITED KINGDOM
S3 7HQ
Insolvency history
No

Corporate ownership

Updated 06 Jun 2026 16:52

Braintrain2020 Limited
No active corporate controller recorded.

Company events

Reference milestones and recent Companies House filing stream events.

7 events
31 May
2027

Accounts due

Accounts Due

Next accounts due date

05 Sep
2026

Confirmation statement due

Confirmation Due

Next confirmation statement due date

31 Aug
2025

Accounts filed

Accounts

Last accounts made up date

22 Aug
2025

Confirmation statement filed

Confirmation

Last confirmation statement made up date

24 Sep
2024

Second Filing Capital Allotment Shares

Capital

RP04SH01 | Transaction MzQzNjk2OTQxMWFkaXF6a2N4 | Paper/PDF filed

Published 26 Sep 2024 06:40

29 Aug
2024

Confirmation Statement With Updates

Confirmation-statement

CS01 | Transaction MzQzMzgzMjA2NWFkaXF6a2N4

Published 29 Aug 2024 15:20

22 Aug
2013

Incorporated

Inception

Company registered at Companies House

Public funding

8 awards
First funded
2015
Funded years
2015, 2017, 2019, 2020, 2021, 2023, 2024, 2025
Age at first award
1 years

Projects

2025 Collaborative R&D Lead participant

Transforming Paediatric Insomnia: A New Sleep Solution for Children to Improve NHS Patient Outcomes

1 Apr 2025 to 30 Sep 2027

Awarded
£270,647
Total cost £386,639

Sleep is a vital component of overall health, yet one-in-three people suffer from insomnia - a condition recognised as a "health epidemic" by the CDC. Over recent years, our understanding of the profound effects that sleep has on both our physical and mental health has grown significantly. A single night of poor sleep can impact a person's mood, alertness...

2024 Collaborative R&D Lead participant

Transforming Sleep: Developing an Patient and Clinician Centred Platform Designed for NHS Systems

1 Oct 2024 to 31 Mar 2025

Awarded
£51,804
Total cost £51,804

Sleep is a vital component of overall health, yet one-in-three people suffer from insomnia - a condition recognised as a "health epidemic" by the CDC. Over recent years, our understanding of the profound effects that sleep has on both our physical and mental health has grown significantly. A single night of poor sleep can impact a person's mood, alertness...

2023 Collaborative R&D Lead participant

New insomnia therapy for children: development of AI for therapy and proof-of-concept trial with Sheffield Children's NHS Foundation Trust

1 Sep 2023 to 28 Feb 2025

Awarded
£205,791
Total cost £293,987

The amount we sleep has been increasingly recognised as having an important impact on our health and well-being. Over recent years we have become increasingly aware of the effects that sleep has on both our physical and mental health. Even one bad night's sleep or late night can affect a person's mood, alertness and memory. The long-term effect of poor sl...

2021 Collaborative R&D Lead participant

Commercialisation of SleepCogni into UK and US sleep clinic market

29 Oct 2021 to 29 Jul 2023

Awarded
£830,000
Total cost £830,000

The amount we sleep has been increasingly recognised as having an important impact on our health and well-being. Over recent years we have become increasingly aware of the effects that sleep has on both our physical and mental health. Even one bad night's sleep or late night can affect a person's mood, alertness and memory. The long-term effect of poor sl...

2020 Feasibility Studies Lead participant

COVID-19 Continuity grant for: Multiple physiological inputs to optimise real-time biofeedback through artificial intelligence to improve sleep in insomniacs

1 Jun 2020 to 31 Mar 2021

Awarded
£77,206
Total cost £77,206

no public description

2019 Collaborative R&D Lead participant

Multiple physiological inputs to optimise real-time biofeedback through artificial intelligence to improve sleep in insomniacs

1 Sep 2019 to 31 May 2021

Awarded
£128,100
Total cost £183,000

The amount we sleep has been increasingly recognised as having an important impact on our health and well-being. Over recent years we have become increasingly aware of the effects that sleep has on both our physical and mental health. Even one bad night's sleep or late night can affect a person's mood, alertness and memory. The long-term effect of poor sl...

2017 Collaborative R&D Lead participant

Product development clinical trial and commercialisation of revolutionary bedside sleep device SleepCogni.

1 Jul 2017 to 31 Dec 2018

Awarded
£324,023
Total cost £462,890

Trouble to fall asleep or waking up in the middle of the night is a problem 1 in 3 around the world face. A lack of sleep leads to unhappiness, reduces performance, increases the risk of accidents and poses severe hazards to health, including cardiovascular disease and cancer. Current treatments for sleep issues do not work or are too costly, and the most...

2015 Vouchers Lead participant

Braintrain2020 Product prototype development & clinical supporting data

1 May 2015 to 31 Oct 2015

Awarded
£5,000
Total cost £5,000

Braintrain2020 Ltd is a drug free, non-invasive electronic sleep aid device which will help insomniacs, stress and anxiety sufferers unwind, relax and switch off a busy mind, making them sleep-ready. Which will mean they fall asleep quicker and enjoy a better quality of sleep.

Product types

Collaborative R&D Feasibility Studies Vouchers